John Allen, M.D., M.B.A.
Dr. Allen’s health services interest is focused on demonstrating high value care delivery especially in the area of colon cancer prevention. Specifically, he is working to optimize the clinical processes of colon cancer risk reduction, screening, surveillance and treatment at a health system level. Anticipating the emergence of alternative payment models, Dr. Allen will compare health outcomes and cost of CRC prevention in various types of health systems.
- M.D., University of New Mexico
- M.B.A., University of St. Thomas
- B.A., Biology/Physiology, Rice University
Health Services Research & Policy Focus
What are you thinking about?
I have an extensive network of contacts in both academic and nonacademic GI practices. I am trying to understand the best business model of practice that will yield highest value cancer prevention. For example, does a fully employed health system model (Kaiser for example) yield better outcomes or higher value compared to a system with affiliated specialty groups?
Why is this interesting to you?
I come from a long association with community-based single specialty GI practice models. These groups associate with large health systems to deliver GI care. If independent practices hope to survive, they must demonstrate added value to a health system that has the option of fully employing specialists. CRC prevention is an excellent model to test these questions.
What are the practical implications for healthcare?
Survival of independent GI practices.